- Q3 2026 revenue of $55.1M vs $54.5M in Q3 2025; diluted EPS fell to $0.11 vs $0.17 YoY.
- Full-year 2026 net income guidance raised to $20–$22M from prior $17–$20M.
- Full-year total revenue guidance adjusted to $224–$227M (prior $224–$231M).
Why is $PBYI moving today? · SEC 8-K archive
$PBYI SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $PBYI: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $PBYI filing catalyst
Why did $PBYI trigger an AI stock catalyst alert?
$PBYI triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Puma Biotechnology Reports Q3 2026 Results, Raises Full-Year Net Income Guidance. Key points: - Q3 2026 revenue of $55.1M vs $54.5M in Q3 2025; diluted EPS fell to $0.11 vs $0.17 YoY. - Full-year 2026 net income guidance raised to $20–$22M from prior $17–$20M. - Full-year total revenue guidance adjusted to $224–$227M (prior $224–$231M).
How did $PBYI stock react after the SEC filing?
After the SEC 8-K for $PBYI, observed market reaction: T0 price $9.77. Past moves do not guarantee future results.
Where can I get real-time $PBYI SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $PBYI via Telegram and the VIP Web Terminal from €10/month.